全球 Omega-3 市場規模：按類型、原產地、應用、地區、範圍和預測

Omega-3 市場規模及預測

2021年Omega-3市場規模為21億美元，預計2022年至2030年複合年增長率為8.21%，到2030年將達到39.3億美元。消費者對健康飲食和 omega-3 健康益處的認識不斷提高，以及臨床研究和開發投資的增加，預計將在預計的幾年內推動 omega-3 市場的發展。 Omega-3 全球市場報告提供了對市場的整體評估。它對關鍵細分市場、趨勢、市場推動因素、阻礙因素、競爭格局以及在市場中發揮關鍵作用的因素進行了全面分析。

全球 omega-3 市場的定義

Omega-3 脂肪酸可降低心臟病的風險並促進皮膚健康。當飲食和運動結合時，omega-3 脂肪酸可以降低血脂（三酸甘油酯）水平並增加 "好" 膽固醇（HDL）水平。它也用於促進高血壓和自體免疫疾病。隨著慢性病的增加，omega-3 市場不斷改變。它被歸類為支持 omega-3 脂肪酸 (DHA)、omega-3 (EPA) 和 omega-3 (ALA)。

全球 omega-3 市場概況

預計未來幾年，消費者對健康飲食和多元不飽和脂肪酸健康邊緣的認識不斷增強，以及對臨床分析和市場開發領域單位的投資不斷增加，預計將促進 omega-3 市場的發展。此外，產品中活性藥物成分 (API) 的使用不斷增加以及人們對慢性病的認識不斷增強，預計將在未來幾年提振市場。

此外，Omega-3 增強免疫力和預防慢性疾病（如狗和貓的惡性疾病和發炎性內臟疾病）的能力預計將在預測期內推動市場發展。還有兩方面的挑戰可能阻礙市場成長。嚴格的監管障礙和 omega-3 單位面積的更好價格等因素無疑是市場阻礙因素。

目錄

第1章全球 omega-3 市場簡介

• 市場概覽
• 調查範圍
• 先決條件

第 2 章執行摘要

第3章驗證市場情報研究方法

• 資料探勘
• 驗證
• 主要來源
• 資料來源列表

第4章全球 Omega-3 市場展望

• 摘要
• 市場動態
  • 促進因素
  • 抑制因素
  • 機會
• 波特的五力模型
• 價值鏈分析

第 5 章全球 omega-3 市場（按類型）

• 摘要
• 二十二碳六烯酸 (DHA)
• 二十碳五烯酸 (EPA)
• ALPHA-亞麻油酸（Ala）

第 6 章 omega-3 的全球市場：依來源劃分

• 摘要
• 海洋起源
• 植物性

第 7 章 Omega-3 全球市場，依應用劃分

• 摘要
• 營養補充品
• 功能性食品和飲料
• 醫學
• 其他

第 8 章按地區劃分的全球 Omega-3 市場

• 摘要
• 北美
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲
  • 德國
  • 英國
  • 法國
  • 歐洲其他地區
• 亞太地區
  • 中國
  • 日本
  • 印度
  • 其他亞太地區
• 世界其他地區
  • 拉丁美洲
  • 中東/非洲

第9章全球omega-3市場競爭態勢

• 摘要
• 公司市場排名
• 主要發展策略

第10章公司簡介

• CRODA INTERNATIONAL
• DSM
• LONZA
• ORKLA HEALTH
• CARGILL
• CORBION
• GC RIEBER
• BASF
• KD PHARMA
• EPAX

第11章 附錄

• 關聯調查

Omega 3 Market Size And Forecast

Omega 3 Market size was valued at USD 2.10 Billion in 2021 and is projected to reach USD 3.93 Billion by 2030 , growing at a CAGR of 8.21% from 2022 to 2030. Rising awareness regarding healthy eating & health benefits of omega-3 among consumers and increasing investment in clinical research & development are expected to drive the Omega 3 Market over the predicted years. The Global Omega 3 Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Omega 3 Market Definition

Omega-3 fatty acids facilitate cut back the danger of cardiopathy and promote healthy skin. This area unit intake in conjunction with diet and exercise to assist lower levels of sure blood fat (triglyceride) and boost levels of "good" cholesteric (HDL). Moreover, it's conjointly wanted to facilitate high-pressure or autoimmune disorders. The ever-changing manner, in conjunction with rising chronic diseases, has contributed to the expansion of the Omega 3 Market. It's classified as supporting the sort together with omega-3 fatty acid (DHA), omega-3 (EPA), and omega-3 (ALA).

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Omega 3 Market Overview

Rising awareness relating to healthy feeding & healthy edges of polyunsaturated fatty acid among customers and increasing investment in clinical analysis & development area units are expected to drive the Omega-3 Market over the expected years. Also, the growing product usage within the Active Pharmaceutical Ingredient (API) and rising awareness of chronic diseases expect to lift the market within the coming years.

Additionally, the power of omega-3 to boost immunity & forestall chronic conditions like malady} & inflammatory internal organ disease in cats and dogs is foretold to fuel the market throughout the forecasted period. There are area unit sure restraints and challenges two-faced which might hinder the market growth. Factors like strict regulation barriers and better prices related to omega-three area units doubtless act as market restraints.

Global Omega 3 Market: Segmentation Analysis

The Global Omega 3 Market is Segmented on the basis of Type, Source, Application, and Geography.

Omega 3 Market, By Type

• Docosahexaenoic Acid (DHA)
• Eicosapentaenoic Acid (EPA)
• Alpha-linolenic Acid (ALA)
• Based on Type, the market is segmented into
• Docosahexaenoic Acid (DHA)
• , Eicosapentaenoic Acid (EPA), and Alpha-linolenic Acid (ALA). Docosahexaenoic Acid (DHA) is predicted to carry the most important market share because of the growing demand for kid formula, which helps in memory retention and learning. Also, it plays a significant role in developing nerve and eye tissues. Global Omega 3 Market, by source

Omega 3 Market, By Source

• Marine Source
• Plant Source

Based on Source, the market is segmented into Marine Source and Plant Source. The marine supply is foretold to carry the foremost important CAGR within the forecasted period as DHA and Environmental Protection Agency area unit synthesized by living thing marine organisms like planktons & Protoctista. The consumption of those organisms helps accumulate polyunsaturated fatty acid fatty acids within the body.

Omega 3 Market, By Application

• Dietary Supplements
• Functional Food & Beverages
• Pharmaceuticals
• Others
• Based on Application, the market is segmented into
• Dietary Supplements
• , Functional Food & Beverages, Pharmaceuticals, and Others. Dietary supplements are units anticipated to own the very best CAGR within the forecasted amount as they're targeted sources of nutrients or alternative substances with an organic process or physiological result.

Omega 3 Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world
• On the basis of Geography, the Global Omega 3 Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. The most important share within the market will be dominated by the Asia Pacific, attributable to the upper demand for fortified food products and the advancements in food technology.

Key Players

• The "Global Omega 3 Market" study report will provide valuable insight with an emphasis on the global market including some of the major players such as
• Croda International, DSM, Lonza, Orkla Health, Cargill, Corbion, GC Rieber, BASF, KD Pharma, and EPAx.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

• Partnerships, Collaborations and Agreements
• On November 2020, Croda International had inked a collaborative partnership with Anomera, an innovative green chemistry Canadian company based in Quebec, focused on developing high-quality Carboxylated Cellulose Nanocrystals which are converted into a micron-sized powder.
• On January 2021, Croda International Plc, the specialty chemical company that uses innovative science to create high-performance ingredients and technologies that improve lives, announced a global sales and marketing agreement with Genesis Biosciences. This new partnership further expands Croda's existing portfolio of safe and sustainable cleaning raw materials.
• On June 2021, Lonza and Moderna Announced a Collaboration For Drug Substance Manufacturing of COVID-19 Vaccine Moderna in the Netherlands. A new drug substance production line at Lonza's site in Geleen, Netherlands, will complement the existing production network and support the manufacture of up to an additional 300 million doses per year.
• On July 2021, Lonza Extends Collaboration with Major Biopharmaceutical Partner for Large-Scale Monoclonal Antibody Commercial Supply. Long-term collaboration for commercial supply of monoclonal antibodies will complete the integrated supply chain to manufacture an antibody-drug conjugate for use against hard-to-treat cancers.
• Mergers and Acquisitions
• On April 2021, The KD Pharma Group has acquired the manufacturing assets of a Swiss-based cannabinoid manufacturer. The acquisitions give KD Pharma access to technology for producing Active Pharmaceutical Ingredients based on phytocannabinoids and other plant extracts.
• On June 2021, Orkla Health acquired NutraQ, and The acquisition will offer Orkla exciting growth opportunities. The health category and direct-to-consumer sales are growing areas and will continue to develop NutraQ's vital concepts while also exploring new possibilities for direct-to-consumer sales.
• On August 2021, Corbion announced it had acquired Granolife, a Queretaro, Mexico-based provider of functional blends for the Mexican bakery and fortification industries. Granolife employs approximately 60 at its production facility and application in the development center.
• Product Launches and Product Expansions
• On January 2021, Corbion increased its capacity for producing lactic acid in North America by around 40% to meet the growing demand for natural ingredients in multiple industries. The investment reinforces the company's leadership position as a supplier of lactic acid and its derivatives worldwide. Corbion also operates lactic acid production facilities in the Netherlands, Brazil, Spain, and Thailand.

TABLE OF CONTENTS

1 INTRODUCTION TO GLOBAL OMEGA 3 MARKET

• 1.1 OVERVIEW OF THE MARKET
• 1.2 SCOPE OF REPORT
• 1.3 ASSUMPTIONS

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 DATA MINING
• 3.2 VALIDATION
• 3.3 PRIMARY INTERVIEWS
• 3.4 LIST OF DATA SOURCES

4 GLOBAL OMEGA 3 MARKET OUTLOOK

• 4.1 OVERVIEW
• 4.2 MARKET DYNAMICS
  • 4.2.1 DRIVERS
  • 4.2.2 RESTRAINTS
  • 4.2.3 OPPORTUNITIES
• 4.3 PORTERS FIVE FORCE MODEL
• 4.4 VALUE CHAIN ANALYSIS

5 GLOBAL OMEGA 3 MARKET, BY TYPE

• 5.1 OVERVIEW
• 5.2 DOCOSAHEXAENOIC ACID (DHA)
• 5.3 EICOSAPENTAENOIC ACID (EPA)
• 5.4 ALPHA-LINOLENIC ACID (ALA)

6 GLOBAL OMEGA 3 MARKET, BY SOURCE

• 6.1 OVERVIEW
• 6.2 MARINE SOURCE
• 6.3 PLANT SOURCE

7 GLOBAL OMEGA 3 MARKET, BY APPLICATION

• 7.1 OVERVIEW
• 7.2 DIETARY SUPPLEMENTS
• 7.3 FUNCTIONAL FOOD & BEVERAGES
• 7.4 PHARMACEUTICALS
• 7.5 OTHERS

8 GLOBAL OMEGA 3 MARKET, BY GEOGRAPHY

• 8.1 OVERVIEW
• 8.2 NORTH AMERICA
  • 8.2.1 U.S.
  • 8.2.2 CANADA
  • 8.2.3 MEXICO
• 8.3 EUROPE
  • 8.3.1 GERMANY
  • 8.3.2 U.K.
  • 8.3.3 FRANCE
  • 8.3.4 REST OF EUROPE
• 8.4 ASIA PACIFIC
  • 8.4.1 CHINA
  • 8.4.2 JAPAN
  • 8.4.3 INDIA
  • 8.4.4 REST OF ASIA PACIFIC
• 8.5 REST OF THE WORLD
  • 8.5.1 LATIN AMERICA
  • 8.5.2 MIDDLE EAST & AFRICA

9 GLOBAL OMEGA 3 MARKET COMPETITIVE LANDSCAPE

• 9.1 OVERVIEW
• 9.2 COMPANY MARKET RANKING
• 9.3 KEY DEVELOPMENT STRATEGIES

10 COMPANY PROFILES

• 10.1 CRODA INTERNATIONAL
  • 10.1.1 OVERVIEW
  • 10.1.2 FINANCIAL PERFORMANCE
  • 10.1.3 PRODUCT OUTLOOK
  • 10.1.4 KEY DEVELOPMENTS
• 10.2 DSM
  • 10.2.1 OVERVIEW
  • 10.2.2 FINANCIAL PERFORMANCE
  • 10.2.3 PRODUCT OUTLOOK
  • 10.2.4 KEY DEVELOPMENTS
• 10.3 LONZA
  • 10.3.1 OVERVIEW
  • 10.3.2 FINANCIAL PERFORMANCE
  • 10.3.3 PRODUCT OUTLOOK
  • 10.3.4 KEY DEVELOPMENTS
• 10.4 ORKLA HEALTH
  • 10.4.1 OVERVIEW
  • 10.4.2 FINANCIAL PERFORMANCE
  • 10.4.3 PRODUCT OUTLOOK
  • 10.4.4 KEY DEVELOPMENTS
• 10.5 CARGILL
  • 10.5.1 OVERVIEW
  • 10.5.2 FINANCIAL PERFORMANCE
  • 10.5.3 PRODUCT OUTLOOK
  • 10.5.4 KEY DEVELOPMENTS
• 10.6 CORBION
  • 10.6.1 OVERVIEW
  • 10.6.2 FINANCIAL PERFORMANCE
  • 10.6.3 PRODUCT OUTLOOK
  • 10.6.4 KEY DEVELOPMENTS
• 10.7 GC RIEBER
  • 10.7.1 OVERVIEW
  • 10.7.2 FINANCIAL PERFORMANCE
  • 10.7.3 PRODUCT OUTLOOK
  • 10.7.4 KEY DEVELOPMENTS
• 10.8 BASF
  • 10.8.1 OVERVIEW
  • 10.8.2 FINANCIAL PERFORMANCE
  • 10.8.3 PRODUCT OUTLOOK
  • 10.8.4 KEY DEVELOPMENTS
• 10.9 KD PHARMA
  • 10.9.1 OVERVIEW
  • 10.9.2 FINANCIAL PERFORMANCE
  • 10.9.3 PRODUCT OUTLOOK
  • 10.9.4 KEY DEVELOPMENTS
• 10.10 EPAX
  • 10.10.1 OVERVIEW
  • 10.10.2 FINANCIAL PERFORMANCE
  • 10.10.3 PRODUCT OUTLOOK
  • 10.10.4 KEY DEVELOPMENTS

11 APPENDIX

• 11.1 RELATED RESEARCH